drugset

drugset / Trial / NCT00412789

Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan

NCT00412789 ↗

Phase 1 Completed 15 enrolled Novartis Pharmaceuticals

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The study will evaluate the safety and efficacy of Patupilone in adult patients with advanced solid tumors.

Timeline

Start: 2006-08
Primary completion: 2008-01
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Patupilone	Small molecule	—	Intravenous

Indications